Omicron-targeted vaccines do no better than original jabs in early tests

Deutschland Nachrichten Nachrichten

Omicron-targeted vaccines do no better than original jabs in early tests
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 Nature
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 68%

Experiments in animals show that boosters customized for the fast-spreading COVID variant offer little advantage over standard jabs.

of either the same shot or a version that incorporated Omicron’s heavily mutated spike protein, which the virus uses to enter human cells. The authors found that monkeys boosted with either vaccine mounted a broad antibody response against all variants of concern, including Omicron., which are responsible for cranking out antibodies to fend off a virus.

“For now, that’s a very good thing,” says Robert Seder, a co-author of the paper and an immunologist at the US National Institute of Allergy and Infectious Diseases in Bethesda, Maryland. “It means we’re still able to cover all known variants with a boost” of the current vaccines. However, he cautions that the study only examined immune responses up to four weeks after the boost, and says that it is not clear how long the increase in antibody production will last.

A study of eight animals isn’t definitive. But given the condensed pandemic-style timescale, the study has value, says Montefiori.in mice found that giving an Omicron-matched booster after two doses of mRNA-based vaccine offered no more benefit than a standard booster. The study also looked at the Omicron-specific vaccine in ‘naive’ mice — those that had not previously been immunized — and found that the rodents produced high levels of potent antibodies against Omicron.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Nature /  🏆 64. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Fourth dose of COVID vaccine offers only slight boost against Omicron infectionIsraeli trial shows a fourth vaccination raises antibody levels but provides little extra protection against SARS-CoV-2 infection.
Weiterlesen »

Moderna co-founder, mRNA developer says he's not completely surprised by vaccine hesitancyModerna co-founder, mRNA developer says he's not completely surprised by vaccine hesitancyRobert Langer, one of the scheduled Imagine Solutions Conference speakers on March 7 in Naples, said the science behind the COVID-19 vaccine is revolutionary
Weiterlesen »

Fourth dose of COVID vaccine offers only slight boost against Omicron infectionIsraeli trial shows a fourth vaccination raises antibody levels but provides little extra protection against SARS-CoV-2 infection.
Weiterlesen »

Stealth Omicron BA.2 now in all U.S. states—here's what we know about the COVID sub-variantStealth Omicron BA.2 now in all U.S. states—here's what we know about the COVID sub-variantAs the Omicron sub-variant (first discovered in late 2021) continues to spread, here's what we know about its characteristics, including vaccine effectiveness.
Weiterlesen »

COVID Omicron News: South Korea has deadliest day of pandemic amid omicron surgeCOVID Omicron News: South Korea has deadliest day of pandemic amid omicron surgeThe country reported 112 fatalities in the latest 24-hour period.
Weiterlesen »

S. Korea has deadliest day of pandemic amid omicron surgeS. Korea has deadliest day of pandemic amid omicron surgeSouth Korea has seen its deadliest day of the pandemic, reporting 112 fatalities in the latest 24-hour period, as it grapples with a wave of coronavirus infections driven by the fast-moving omicron variant
Weiterlesen »



Render Time: 2025-03-10 19:06:38